Why We Don’t Offer ADHD Medication Before a Full Assessment

Why We Don’t Offer ADHD Medication Before a Full Assessment

In recent years, awareness of ADHD has grown significantly. This has helped many people finally recognise lifelong difficulties and seek support. However, alongside this increased awareness, there has also been a worrying trend: some services offering ADHD medication before a full diagnostic assessment has taken place.

At Private ADHD Assessment Doncaster, we take a firm and principled stance on this:

We do not prescribe ADHD medication unless a full, NICE-compliant assessment has been completed first.

This decision is rooted in clinical safety, ethical responsibility, and good medical practice — not convenience, speed, or profit.

Medication Is Not a Starting Point — It’s a Clinical Decision

ADHD medication is not benign. While it can be life-changing when used appropriately, it is still powerful pharmacological treatment, often involving controlled drugs such as methylphenidate or lisdexamfetamine.

Prescribing medication without first establishing:

• whether ADHD is actually present,

• whether medication is clinically indicated,

• and whether it is safe for that individual,

is unsafe and unethical.

Before medication is even considered, clinicians must understand:

• the person’s neurodevelopmental profile,

• alternative explanations for symptoms,

• physical health risks,

• mental health history,

• and current medications.

Without this, prescribing becomes guesswork.

You Can’t Treat What You Haven’t Diagnosed

ADHD symptoms can overlap with many other presentations, including:

• anxiety disorders,

• trauma responses,

• attachment difficulties,

• learning differences,

• sleep disorders,

• sensory processing difficulties,

• mood disorders,

• environmental stress.

If medication is offered before a proper assessment, there is a real risk that:

• ADHD is incorrectly assumed,

• the underlying difficulty is missed,

• medication masks symptoms without addressing the cause,

• or the wrong treatment is given entirely.

This is why NICE guidance is clear that diagnosis must come before medication.

Prescribing before diagnosis raises a very simple question:

How can you treat something you haven’t confirmed exists?

Safety Comes Before Speed

ADHD medications affect:

• heart rate,

• blood pressure,

• appetite,

• sleep,

• emotional regulation,

• anxiety levels.

Before prescribing, clinicians must check for:

• cardiac history (including family history),

• blood pressure and pulse,

• growth parameters (in children),

• existing mental health conditions,

• known allergies,

• current medications and potential interactions.

For example:

• stimulant medication may worsen anxiety in some individuals,

• certain cardiac conditions are contraindications,

• interactions with antidepressants, blood pressure medication, or asthma treatments must be considered.

Prescribing without this knowledge is not just poor practice — it can be dangerous.

Ethical Concerns: Paying for Medication Without Knowing If It’s Appropriate

There is also an ethical issue that is rarely discussed openly.

If a service offers medication before assessment, they are asking individuals or families to pay for treatment without knowing:

• whether ADHD is present,

• whether medication is appropriate,

• whether medication will be recommended at all.

This places the financial burden before clinical justification.

In healthcare, this is deeply problematic.

Ethical practice requires that:

• diagnosis is evidence-based,

• treatment decisions are justified,

• and costs are transparent and proportionate to clinical need.

Anything else risks prioritising income over patient welfare.

Our Approach: Diagnosis First, Treatment Second

At Private ADHD Assessment Doncaster, our pathway is deliberately structured to protect patients.

We:

1. Assess first — using NICE-aligned diagnostic processes.

2. Consider alternatives — ADHD is not assumed.

3. Formulate clinically — not based on one tool or one opinion.

4. Decide collaboratively — medication is one option, not the only option.

5. Prescribe safely — only when clinically indicated and appropriate.

6. Monitor carefully — following national guidance.

Medication is never guaranteed, promised, or implied.

And that is exactly how it should be.

Why This Matters for NHS Recognition and Shared Care

GPs, CAMHS, and NHS services expect private providers to follow the same standards they do. When medication is prescribed without proper assessment:

• shared care agreements are often refused,

• reports are challenged,

• patients are left stuck between systems.

By doing things properly from the outset, we ensure that:

• our reports are respected,

• our prescribing decisions are defensible,

• and patients are not put in a vulnerable position later.

In Summary

We don’t prescribe ADHD medication before assessment because:

• We don’t know if ADHD is present.

• We don’t know if medication is safe.

• We don’t know if medication is appropriate.

• We don’t believe in asking people to pay for treatment without justification.

• We believe diagnosis and prescribing must be ethical, evidence-based, and patient-centred.

This approach may take slightly longer — but it is safer, more respectful, and ultimately more effective.

References & Further Reading

• National Institute for Health and Care Excellence (NICE).Attention deficit hyperactivity disorder: diagnosis and management (NG87).NICE, updated guidance.

• British National Formulary (BNF).Central nervous system stimulants — prescribing and safety considerations.

• Cortese S et al. (2018).Comparative efficacy and tolerability of medications for ADHD.The Lancet Psychiatry.

• NHS England.Shared care protocols for ADHD medication.

• Royal College of Psychiatrists.ADHD in adults: good practice guidelines.